Neutralizing antibody response to different COVID-19 vaccines in Brazil: the impact of previous infection and booster doses

IntroductionIn Brazil, three COVID-19 vaccines were among the first widely used (CoronaVac, ChAdOx1, and BNT162b2), which aimed to induce neutralizing antibodies (NAbs) against the original SARS-CoV-2 strain. Although effective against severe disease, they showed waning NAb levels and reduced effica...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Beatriz L. L. Caetano, Paolla B. A. Pinto, Agatha R. Pacheco, Agnes R. Lage, Aline S. G. Pereira, Amanda V. P. Nascimento, Thiago R. Machado, Anderson Paulino, Thiago L. Medeiros, Lorena O. Fernandes-Siqueira, Andrea T. Da Poian, Ingrid S. Horbach, Adriana S. Azevedo, Simone M. Costa, Ada M. B. Alves
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2025-08-01
Sarja:	Frontiers in Immunology
Aiheet:	COVID-19 vaccine neutralizing antibodies booster dose SARS-CoV-2
Linkit:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1603612/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!